GA-UHT
26.4.2022 09:02:17 CEST | Business Wire | Press release
Unibloc Pump, a leader in positive displacement pumps and other highly engineered products for demanding hygienic flow control applications, has rebranded to Unibloc Hygienic Technologies (UHT). The rebranding follows the company’s expansion of its family of hygienic flow control brands, most recently through its acquisitions of Flotronic Pumps and Standard Pump.
- Flotronic Pumps: UK-based manufacturer of specialized, air-operated double diaphragm (AODD) pumps and associated accessories primarily for hygienic flow control applications (acquired by Unibloc Pump in August 2021)
- Standard Pump: Georgia-based manufacturer of hygienic and industrial process pumps, including drum pumps and other fluid handling equipment (acquired by Unibloc Pump in December 2021)
"All three companies – Unibloc, Flotronic, and Standard Pump – have each built a leading reputation for quality manufacturing, innovative design and excellent customer service,” said Chris Stevens, CEO of Unibloc Hygienic Technologies. “Our new market identity communicates to customers that today we offer a much more expansive line of hygienic product solutions for a wider variety of applications. No other company can match the process and application experience the UHT team brings to our customers.”
Each company’s products are represented now as subsidiary brands under the Unibloc Hygienic Technologies umbrella, with identities that tie them together. Additionally, a new brand, Hygenitec, has been created to represent a range of additional hygienic flow control products, such as valves, strainers, sight glasses, drum pumps and bubble traps.
“Customers are more time-pressed than ever before, and more focused on building best-in-class systems in their facilities,” said Mark Boyd, vice president of sales at Unibloc Hygienic Technologies. “As a result, we have designed our approach to the market to make it simpler and faster for customers to get the information they need on a wider variety of product solutions, all from a single company and a single point of contact.”
About Unibloc Hygienic Technologies
An industry leader in flow control technology and performance, Unibloc Hygienic Technologies offers precision-engineered positive displacement pumps, AODD pumps, drum pumps, and other highly engineered products for demanding hygienic flow control applications. UHT serves a variety of hygienic industries, including food, beverage, bakery/confection, meat and poultry, brewery, pharmaceutical, and transportation, under the Unibloc, Flotronic, Standard Pump, and Hygenitec subsidiary brands. UHT’s highly efficient, easy-to-maintain products help customers fight downtime, achieve a lower cost of operation, and meet deadlines with confidence. Learn more at www.unibloctech.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220426005207/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom